首页|期刊导航|Cancer Innovation|Re‐Innovation in Clinical Trial Designs Based on Precision Therapy

Re‐Innovation in Clinical Trial Designs Based on Precision Therapy

Shenglan Li Jiachen Wang Zhuang Kang Xun Kang Feng Chen Wenbin Li

Cancer Innovation2025，Vol.4Issue(5)：P.75-82,8.

Cancer Innovation2025，Vol.4Issue(5)：P.75-82,8.DOI:10.1002/cai2.70028

Re‐Innovation in Clinical Trial Designs Based on Precision Therapy

Shenglan Li ¹Jiachen Wang ¹Zhuang Kang ¹Xun Kang ¹Feng Chen ¹Wenbin Li¹

作者信息

1. Department of Neuro‐Oncology,Cancer Center,Beijing Tiantan Hospital,Capital Medical University,Beijing,China
折叠

摘要

关键词

adaptive trials/biomarkers/clinical trials/precision medicine

分类

医药卫生

引用本文复制引用

Shenglan Li,Jiachen Wang,Zhuang Kang,Xun Kang,Feng Chen,Wenbin Li..Re‐Innovation in Clinical Trial Designs Based on Precision Therapy[J].Cancer Innovation,2025,4(5):P.75-82,8.

基金项目

funded by Talent Introduction Fund of Beijing Tiantan Hospital(RCYJ‐2020‐2025‐LWB) （RCYJ‐2020‐2025‐LWB）

the Beijing Clinical Key Specialty Project(2‐1‐2‐038) （2‐1‐2‐038）

National Natural Science Foundation(32471036) （32471036）

National Natural Science Foundation Youth Fund(82303822). （82303822）

Cancer Innovation

ISSN：2770-9191

访问量1

下载量0

段落导航